BRIEF published on 09/24/2025 at 09:35, 2 months 10 days ago LIBERO Football Finance AG Boosts Equity with EUR 1.25 Million Capital Measures Equity Strengthening Capital Measures LIBERO Football Finance Soccer Club Deals Legal Dispute FC Barcelona
PRESS RELEASE published on 09/24/2025 at 09:30, 2 months 10 days ago Capital measures totaling EUR 1.25 million successfully implemented LIBERO football finance AG successfully implements capital measures totaling EUR 1.25 million to strengthen equity capital, eliminating deficit and launching new business model Capital Increase Equity Capital Financial Support LIBERO Football Finance AG Soccer Clubs
BRIEF published on 09/16/2025 at 16:49, 2 months 18 days ago LIBERO football finance AG Announces New Capital Measures Voting Rights Frankfurt Stock Exchange LIBERO Football Finance AG Capital Measures Subscription Shares
PRESS RELEASE published on 09/16/2025 at 16:44, 2 months 18 days ago Other capital measures (Section 41 (1) WpHG) LIBERO football finance AG announces capital increase and other capital measures. New total number of voting rights: 40,360,000 Voting Rights Capital Increase LIBERO Football Finance AG Corporate Action Section 41 WpHG
BRIEF published on 08/29/2025 at 07:05, 3 months 6 days ago LIBERO Football Finance AG Releases 2025 Half-Year Report Financial Performance Corporate Strategy LIBERO Football Finance Football Financing 2025 Half-Year Report
PRESS RELEASE published on 08/29/2025 at 07:00, 3 months 6 days ago Publication of the 2025 Half-Year Report LIBERO football finance AG announces the publication of its 2025 Half-Year Report, featuring financial results and future corporate strategy focused on football financing services Financial Results LIBERO Football Finance AG Corporate Strategy Football Financing 2025 Half-Year Report
BRIEF published on 08/15/2025 at 07:05, 3 months 20 days ago LIBERO football finance AG Reports 2024 Annual Financial Loss LIBERO Football Finance AG Net Loss 2024 Annual Financial Statement FC Barcelona Legal Proceedings Football Financing Strategy
PRESS RELEASE published on 08/15/2025 at 07:00, 3 months 20 days ago Publication of the 2024 annual financial statements LIBERO football finance AG announces the publication of its 2024 annual financial statements, closing with a net loss of EUR 783 thousand. Refusal of auditor to issue an opinion discussed, ongoing legal proceedings in Spain cited LIBERO Football Finance AG Net Loss Legal Proceedings 2024 Annual Financial Statements Auditor Opinion Refusal
BRIEF published on 07/01/2025 at 21:00, 5 months 3 days ago Delay in LIBERO football finance AG's 2024 Financial Report Capital Increase Management Changes LIBERO Football Finance 2024 Financial Delay FC Barcelona Deal
PRESS RELEASE published on 07/01/2025 at 20:55, 5 months 3 days ago Delay in the Publication of the 2024 Annual Financial Statements LIBERO football finance AG delays the publication of its 2024 Annual Financial Statements due to capital increase and pending Barcelona transaction. New Chairman appointed Capital Increase LIBERO Football Finance AG Delay 2024 Annual Financial Statements Barcelona Transaction
Published on 12/05/2025 at 02:35, 3 hours 30 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 5 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 5 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 49 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 5 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 20 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 20 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 4 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
